Article Details

Chance Pharmaceuticals Secures $30 Million Series C Funding to Advance Innovative ... - Benzinga

Retrieved on: 2021-10-11 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

Chance Pharmaceuticals Secures $30 Million Series C Funding to Advance Innovative ... - Benzinga. View article details on hiswai:

Excerpt

HANGZHOU, China, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Chance Pharmaceuticals ("Chance"), a clinical-stage biotechnology company focusing on discovering, ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up